Recognizing the new opportunities offered by next generation sequencing technologies in the field of cancer genomics, the French National Cancer Institute (INCa) has pledged to provide a major contribution to the International Cancer Genome Consortium (ICGC) through the study of two cancer types (hepatocellular carcinoma and HER2 amplified breast tumors). The entire sequencing of multiple pairs of tumor and matched germline DNAs has already been completed and other pairs are rapidly following. In order to overcome the challenges raised by the massive amount of sequence data that has been and will be generated by such programs, INCa and the Lyon community through the Synergie Lyon Cancer Foundation are joining efforts to create a dedicated bioinformatics facility. The objective of the bioinformatics facility is to empower the biomedical teams working in the field of cancer to best exploit the data generated through large scale genomic projects, notably those funded by INCa and in the first place those taking place within the ICGC. The facility is located on the campus of the Comprehensive Cancer Center Leon Berard and is a componenet of the "Pole Rhone-Alpes de Bioinformatique, PRABI, which federates major bioinformatic teams. Thus the facility benefits both from strong biomedical and bioinformatics environments.
Director : Pr. Gilles Thomas
Administrative Assistant :
- Emilie Thomas : Statistical Expertise
- Vincent LeTexier : Databases Expertise
- Anthony Ferrari : Data Analysis and computer science
- Aurélie Laugraud : Data Analysis and system management